Long-term caffeine worsens anxiety symptoms and fear of the new associated with Alzheimer's disease

April 3, 2018, Autonomous University of Barcelona

A study coordinated by the Institute of Neuroscience of the Universitat Autònoma de Barcelona (Inc-UAB) and in collaboration with the Karolinska Institutet (KI) in Sweden provides evidence that a long-term consumption of caffeine has negative effects for Alzheimer's disease, worsening the neuropsychiatric symptoms appearing in the majority of those affected by the disorder. The research was recently published in Frontiers in Pharmacology.

Memory problems are the hallmark of Alzheimer's . However, this dementia is also characterised by , which may be observed in the earliest stages of the disorder. Known as behavioural and psychological symptoms of dementia (BPSD), the symptoms include anxiety, apathy, depression, hallucinations, paranoia and sundowning. They are considered the strongest source of distress for patients and caregivers.

Coffee or caffeine has recently been suggested as a strategy to prevent dementia, both in patients with Alzheimer's disease and in normal ageing processes, due to its action in blocking molecules – adenosine receptors – which may cause dysfunctions and diseases in old age. However, there is some evidence that once the cognitive but also the NPS symptoms are developed, caffeine may exert opposite effects.

To address these issues, the study was conducted with normal ageing mice and familial Alzheimer's models. "The mice develop Alzheimer's disease similarly to human patients with an early-onset form of the disease. They not only exhibit the typical cognitive problems but also a number of BPSD-like symptoms, so it is a valuable model to address whether the benefits of caffeine will be able to compensate its putative ," says Raquel Baeta-Corral, first author of the research.

"We had previously demonstrated the importance of the adenosine A1 receptor as the cause of some of caffeine's adverse effects. Now, we have simulated a long oral treatment with a very low dose of caffeine (0.3 mg/mL) equivalent to three cups for a human coffee-drinker to answer a question relevant for patients with Alzheimer's, but also for the ageing population in general, and that in humans would take years to be solved since we should wait until the patients were aged," says Dr. Björn Johansson, researcher and physician at the Karolinska University Hospital. The research was conducted from the onset of the disease to more advanced stages. Healthy, age-matched mice provided control data.

The results indicate that caffeine alters the behaviour of healthy mice and worsens the neuropsychiatric symptoms of mice with Alzheimer's disease. The researchers discovered significant effects in the majority of variables studies, especially in relation to neophobia, a fear of everything new, anxiety-related behaviours, and emotional and cognitive flexibility.

In with Alzheimer's disease, the increase in neophobia and anxiety-related behaviours exacerbates their BPSD-like profile. Learning and memory, strongly influenced by anxiety, got little benefit from caffeine.

"Our observations of adverse caffeine effects in an Alzheimer´s disease model together with previous clinical observations suggest that an exacerbation of BPSD-like symptoms may partly interfere with the beneficial cognitive effects of . These results are relevant when coffee-derived new potential treatments for dementia are to be devised and tested," says lead researcher Dr. Lydia Giménez-Llort of the INc-UAB Department of Psychiatry and Legal Medicine.

Explore further: Evaluation and treatment of depression may reverse memory and cognitive difficulties

More information: Raquel Baeta-Corral et al. Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer's Disease and Affects Mice with Normal Aging, Frontiers in Pharmacology (2018). DOI: 10.3389/fphar.2018.00079

Related Stories

Evaluation and treatment of depression may reverse memory and cognitive difficulties

March 27, 2018
Individuals with worse depression and mood symptoms are more likely to develop Mild Cognitive Impairment (MCI) and to progress from MCI to dementia. Evaluation and treatment of symptoms of depression may improve or maintain ...

Blood vessels also affected by Alzheimer's disease

March 19, 2018
Researchers from the Institute of Neuroscience at the Universitat Autònoma de Barcelona (INc-UAB) have demonstrated for the first time that anxiety and problems with blood vessels present a close relationship with Alzheimer's ...

Caffeine as a biomarker for Parkinson's disease

February 15, 2018
Researchers at Juntendo University report in Neurology the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson's disease. The finding is promising for the development of a method enabling ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

Caffeine level in blood may help diagnose people with Parkinson's disease

January 3, 2018
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the ...

Can caffeine be used to treat or prevent Alzheimer's disease?

March 31, 2015
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid ...

Recommended for you

Hypothesis underpinning dementia research 'flawed'

October 16, 2018
A hypothesis which has been the standard way of explaining how the body develops Alzheimer's Disease for almost 30 years is flawed, according to a University of Manchester biologist.

Many cases of dementia may arise from non-inherited DNA 'spelling mistakes'

October 15, 2018
Only a small proportion of cases of dementia are thought to be inherited—the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications, a team of scientists led by researchers ...

Scientists create new map of brain region linked to Alzheimer's disease

October 8, 2018
Curing some of the most vexing diseases first requires navigating the world's most complex structure—the human brain. So, USC scientists have created the most detailed atlas yet of the brain's memory bank.

Previously unknown genetic aberrations found to be associated with Alzheimer's progression

October 8, 2018
In a large-scale analysis of RNA from postmortem human brain tissue, researchers at the Icahn School of Medicine at Mount Sinai and Columbia University have identified specific RNA splicing events associated with Alzheimer's ...

Periodontal disease bacteria may kick-start Alzheimer's

October 4, 2018
Long-term exposure to periodontal disease bacteria causes inflammation and degeneration of brain neurons in mice that is similar to the effects of Alzheimer's disease in humans, according to a new study from researchers at ...

AI could predict cognitive decline leading to Alzheimer's disease in the next five years

October 4, 2018
A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.